PLX

PLX Gross Profit Growth

56.54%TTM

Period ending:

PLX TTM Gross Profit YoY %%
PLX TTM Gross Profit YoY %5161.43%-748.60%
1999-06-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

PLX gross profit growth history

Year-over-year gross profit growth rate. The available trailing twelve months (ttm) series contains 77 observations from Jun 30, 1999 to Jun 30, 2026.

Protalix Biotherapeutics Inc Gross Profit Growth — Trailing twelve months (TTM)
Period endingGross Profit Growth
56.5424%
78.9299%
-11.4477%
117.2426%
191.0093%
-19.6151%
-31.5958%
-65.2287%
-74.8846%
51.6654%
51.5795%
72.9974%
71.2705%
-3.9181%
27.476%
-18.3427%
-13.5049%
-36.8261%
-57.7107%
-33.4351%
-38.1455%
-24.7352%
18.784%
-6.771%
0.2034%
23.6288%
19.634%
320.2503%
1,287.6143%
796.3629%
812.74%
296.4341%
74.9886%
234.6473%
400.7491%
172.1799%
257.3381%
487.6676%
-9.0806%
-176.6644%
-132.8062%
-108.8662%
-85.5739%
-0.7155%
-26.0945%
-34.2451%
0.3615%
9.0065%
-13.6076%
-76.9225%
-77.5751%
-81.1443%
-74.6843%
591.1992%
297.5824%
4,589.491%
1,178.0595%
56.6797%
476.0331%
-33.8043%
271.0592%
209.4017%
43.0499%
-100%
-100%
-100%
-100%
-100%
-100%
-100%
-100%
-99.269%
-99.2527%
-94.4333%
-83.1823%
-17.7865%
206.5709%

Compare gross profit growth

All PLX financial metrics · PLX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.